Afuco™ Anti-Human APCDD1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-APCDD1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-APCDDl antibodies are used for the immunotherapeutic treatment of malignancies including, for example, KRAS and/or APC mutated colorectal cancer and KRAS mutated pancreatic cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-044CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | APCDD1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |